Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5)

Drug Metabolism Reviews

Volumn 37, Issue 1, 2005, Pages 253-278

  Ritter, Christoph A ^a   Jedlitschky, Gabriele ^a   Meyer Zu Schwabedissen, Henriette ^a   Grube, Markus ^a   Köck, Kathleen ^a   Kroemer, Heyo K ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

ABC transporters; Anticancer drugs; Antiviral drugs; Cyclic nucleotides; Drug resistance

Indexed keywords

ABACAVIR; ADEFOVIR; ANTIMONY TARTRATE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CARRIER PROTEIN; CLADRIBINE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; DIDANOSINE; FLUORESCEIN DIACETATE; FLUOROURACIL; GANCICLOVIR; GEMCITABINE; GLUTATHIONE; LAMIVUDINE; MERCAPTOPURINE; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; NUCLEIC ACID BASE; NUCLEOTIDE DERIVATIVE; PHOSPHODIESTERASE; PROSTAGLANDIN DERIVATIVE; STAVUDINE; STEROID; TIOGUANINE; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NERVE CELL; NUCLEOTIDE TRANSPORT; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE; VIRUS INHIBITION;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; HUMANS; METABOLIC DETOXICATION, DRUG; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHARMACEUTICAL PREPARATIONS;

EID: 13844275028     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-47984     Document Type: Review

References (80)

1. Adachi, M., Sampath, J., Lan, L. B., Sun, D., Hargrove, P., Flatley, R., Tatum, A., Edwards, M. Z., Wezeman, M., Matherly, L., Drake, R., Schuetz, J. (2002). Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J. Biol. Chem. 277:38998-39004.
2. Aktas, B., Utz, A., Hoenig-Liedl, P., Walter, U., Geiger, J. (2003). Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke 34:764-769.
3. Ashman, D. F., Lipton, R., Melicow, M. M., Price, T. D. (1963). Isolation of adenosine 3′, 5′-monophosphate and guanosine 3′, 5′-monophosphate from rat urine. Biochem. Biophys. Res. Commun. 11:330-334.
4. Balzarini, J., Aquaro, S., Knispel, T., Rampazzo, C., Bianchi, V., Perno, C. F., De Clercq, E., Meier, C. (2000). Cyclosaligenyl-2′,3′- didehydro-2′,3′-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP. Mol. Pharmacol. 58:928-935.
5. Baulieu, E. E., Robel, P. (1998). Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. U. S. A. 95:4089-4091.
6. Baulieu, E. E. (1996). Dehydroepiandrosterone (DHEA): a fountain of youth? J. Clin. Endocrinol Metab. 81:3147-3151.
7. Beck, C., Cayeux, S., Lupton, S. D., Dorken, B., Blankenstein, T. (1995). The thymidine kinase/ganciclovir-mediated ′suicide′ effect is variable in different tumor cells. Hum. Gene Ther. 6:1525-1530.
8. Belinsky, M. G., Bain, L. J., Balsara, B. B., Testa, J. R., Kruh, G. D. (1998). Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J. Natl. Cancer Inst. 90:1735-1741.
9. Bellamy, T. C., Wood, J., Goodwin, D. A., Garthwaite, J. (2000). Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci. U. S. A. 97:2928-2933.
10. Billiar, T. R., Curran, R. D., Harbrecht, B. G., Stadler, J., Williams, D. L., Ochoa, J. B., Di Silvio, M., Simmons, R. L., Murray, S. A. (1992). Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am. J. Physiol. 262:C1077-C1082.
11. Borst, P., Elferink, R. O. (2002). Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71:537-592.
12. Brunton, L. L., Heasley, L. E. (1988). cAMP export and its regulation by prostaglandin Al. Methods Enzymol. 159:83-93.
13. Butcher, R. W., Sutherland, E. W. (1962). Adenosine 3′,5′- phosphate in biological materials. I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine. J. Biol. Chem. 237:1244-1250.
14. Carvajal, J. A., Germain, A. M., Huidobro-Toro, J. P., Weiner, C. P. (2000). Molecular mechanism of cGMP-mediated smooth muscle relaxation. J. Cell. Physiol. 184:409-420.
15. Chen, Z. S., Lee, K., Kruh, G. D. (2001). Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 276:33747-33754.
16. Chen, Z. S., Lee, K., Walther, S., Raftogianis, R. B., Kuwano, M., Zeng, H., Kruh, G. D. (2002). Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a compone nt of the methotrexate efflux system. Cancer Res. 62:3144-3150.
17. Dallas, S., Schlichter, L., Bendayan, R. (2004). Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl) adenine by microglia. J. Pharmacol. Exp. Ther. 309:1221-1229.
18. Dantzig, A. H., Pratt, S. E., Shepard, R. L. (2003). MRP5 confers resistance to 5-FU and transports a phosphorylated metabolite of 5-FU. Proc. Am. Assoc. Cancer Res. 44:735.
19. Davidson, J. D., Ma, L., Iverson, P. W., Lesoon, A., Jin, S., Horwitz, L., Gallery, M., Slapak, C. A. (2002). Human multidrug resistance protein 5 (MRP5) confers resistance to gemcitabine. Proc. Am. Assoc. Cancer Res. 43:780-781.
20. Dazert, P., Meissner, K., Vogelgesang, S., Heydrich, B., Eckel, L., Bohm, M., Warzok, R., Kerb, R., Brinkmann, U., Schaeffeler, E., Schwab, M., Cascorbi, I., Jedlitschky, G., Kroemer, H. K. (2003). Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart. Am. J. Pathol. 163:1567-1577.
21. De Clercq, E. (2003). Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin. Microbiol Rev. 16:569-596.
22. Fehr, T. F., Dickinson, E. S., Goldman, S. J., Slakey, L. L. (1990). Cyclic AMP efflux is regulated by occupancy of the adenosine receptor in pig aortic smooth muscle cells. J. Biol. Chem. 265:10974-10980.
23. Flesch, M., Kilter, H., Cremers, B., Lenz, O., Sudkamp, M., Kuhn-Regnier, F., Bohm, M. (1997). Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J. Pharmacol. Exp. Ther. 281:1340-1349.
24. Flesch, M., Kilter, H., Cremers, B., Laufs, U., Sudkamp, M., Ortmann, M., Muller, F. U., Bohm, M. (1999). Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J. Am. Coll. Cardiol. 33:1062-1070.
25. Garthwaite, J. (1995). Neural nitric oxide signalling. Trends Neurosci. 18:51-52.
26. Guo, Y., Kotova, E., Chen, Z. S., Lee, K., Hopper-Borge, E., Belinsky, M. G., Kruh, G. D. (2003). MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl) adenine. J. Biol. Chem. 278:29509-29514.
27. Haimeur, A., Conseil, G., Deeley, R. G., Cole, S. P. (2004). The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug Metab. 5:21-53.
28. Hamet, P., Pang, S. C., Tremblay, J. (1989). Atrial natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J. Biol. Chem. 264:12364-12369.
29. Hatse, S., De Clercq, E., Balzarini, J. (1998). Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl) adenine-resistant human erythroleukemia K562 cell line. Mol. Pharmacol. 54:907-917.
30. Hirrlinger, J., Konig, J., Dringen, R. (2002). Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J. Neurochem. 82:716-719.
31. Janssens, P. M., van Essen, H. W., Guijt, J. J., de Waal, A., van Driel, R. (1987). Cell fractionation, detergent sensitivity and solubilization of Dictyostelium adenylate cyclase and guanylate cyclase. Mol. Cell. Biochem. 76:55-65.
32. Jedlitschky, G., Keppler, D. (2002). Transport of leukotriene C4 and structurally related conjugates. Vitam. Horm. 64:153-184.
33. Jedlitschky, G., Burchell, B., Keppler, D. (2000). The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275:30069-30074.
34. Jedlitschky, G., Tirschmann, K., Lubenow, L. E., Nieuwenhuis, H. K., Akkerman, J. W., Greinacher, A., Kroemer, H. K. (2004). The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood. 104:3603-3640.
35. Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., Borst, P. (1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:3537-3547.
36. Kruh, G. D., Belinsky, M. G. (2003). The MRP family of drug efflux pumps. Oncogene 22:7537-7552.
37. Lai, L., Tan, T. M. (2002). Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem. J. 361:497-503.
38. Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., Kruh, G. D. (1998). Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res. 58:2741-2747.
39. Lee, K., Klein-Szanto, A. J., Kruh, G. D. (2000). Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J. Natl. Cancer Inst. 92:1934-1940.
40. Lee, K. H., Piao, H., Son, B. R., Heo, D. S., Kim, N. K., Kim, S. T. (2004). Herpes simplex virus thymidine kinase and granulocyte macrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model. Cancer Gene Ther. 11:570-576.
41. Leggas, N., Adachi, N., Schetter, G. L., Sun, D., Wielinga, P., Du, E., Mercer, K. E., Zhuang, Y., Panetta, J. C., Johnston, C., Schepes, R. J., Steward, C. F., Schuetz, J. D. (2004). MRP4 confers resistance to topotecan and protect the brain from chemotherapy. Oncogene 24:7612-7621.
42. Maatta, A. M., Tenhunen, A., Pasanen, T., Merilainen, O., Pellinen, R., Makinen, K., Alhava, E., Wahlfors, J. (2004). Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy. Int. J. Oncol. 24:943-949.
43. Maeda, Y., Ikeda, U., Oya, K., Shimpo, M., Ueno, S., Urabe, M., Kume, A., Monahan, J., Ozawa, K., Shimada, K. (2001). Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes. Cardiovasc. Drugs Ther. 15:19-24.
44. McAleer, M. A., Breen, M. A., White, N. L., Matthews, N. (1999). pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J. Biol. Chem. 274:23541-23548.
45. Meyer zu Schwabedissen, H., Jedlitschky, G., Linnemann, K., Fusch, C., Kroemer, H. K. (2005). MRP5 expresison in human placenta. Am. J. Pathol. 166:39-48.
46. Millul, V., Prie, D., Geniteau-Legendre, M., Verpont, M. C., Baudouin, B., Ronco, P. M. (1996). ANP-stimulated cGMP egression in renal principal cells: abrogation of polarity by SV40 large T. Am. J. Physiol. 270:C1051-C1060.
47. Moncada, S., Palmer, R. M., Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
48. Muller, T. H. (2001). Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction. Neurology 57:S8-S11.
49. Nandagopal, K., Dawson, T. M., Dawson, V. L. (2001). Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J. Pharmacol. Exp. Ther. 297:474-478.
50. Nies, A. T., Konig, J., Cui, Y., Brom, M., Spring, H., Keppler, D. (2002). Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). Eur. J. Biochem. 269:1866-1876.
51. Nies, A. T., Spring, H., Thon, W. F., Keppler, D., Jedlitschky, G. (2002). Immunolocalization of multidrug resistance protein 5 in the human genitourinary system. J. Urol. 167:2271-2275.
52. Nies, A. T., Jedlitschky, G., König, J., Herold-Mende, C., Steiner, H. H., Schmitt, H.-P., Keppler, D. (2004). Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129:349-360.
53. Oh, J., Bailin, T., Fukai, K., Feng, G. H., Ho, L., Mao, J. I., Frenk, E., Tamura, N., Spritz, R. A. (1996). Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat. Genet. 14:300-306.
54. Parratt, J. R., Vegh, A., Papp, J. G. (1995). Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning - a brief review of the evidence. Can. J. Physiol. Pharm. 73:837-842.
55. Patel, M. J., Wypij, D. M., Rose, D. A., Rimele, T. J., Wiseman, J. S. (1995). Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide. J. Pharmacol. Exp. Ther. 273:16-25.
56. Prados, M. D., McDermott, M., Chang, S. M., Wilson, C. B., Fick, J., Culver, K. W., Van Gilder, J., Keles, G. E., Spence, A., Berger, M. (2003). Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multiinstitutional trial. J. Neurooncol. 65:269-278.
57. Reid, G., Wielinga, P., Zelcer, N., de Haas, M., van Deemter, L., Wijnholds, J., Balzarini, J., Borst, P. (2003a). Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63:1094-1103.
58. Reid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., Borst, P. (2003b). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. U. S. A. 100:9244-9249.
59. Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., Keppler, D. (2003). Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38:374-384.
60. Robbins, B. L., Connelly, M. C., Marshall, D. R., Srinivas, R. V., Fridland, A. (1995). A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent. Mol. Pharmacol. 47:391-397.
61. Rubsam, L. Z., Boucher, P. D., Murphy, P. J., KuKuruga, M., Shewach, D. S. (1999). Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells. Cancer Res. 59:669-675.
62. Sager, G., Orbo, A., Pettersen, R. H., Kjorstad, K. E. (1996). Export of guanosine 3′,5′-cyclic monophosphate (cGMP) from human erythrocytes characterized by inside-out membrane vesicles. Scand. J. Clin. Lab. Invest. 56:289-293.
63. Savaraj, N., Wu, C., Wangpaichitr, M., Kuo, M. T., Lampidis, T., Robles, C., Furst, A. J., Feun, L. (2003). Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine. Int. J. Oncol. 23:173-179.
64. Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., Fridland, A. (1999). MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med. 5:1048-1051.
65. Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R. B., Ramachandran, V., Komoroski, B. J., Venkataramanan, R., Cai, H., Sinai, C. J., Gonzalez, F. J., Schuetz, J. D. (2001). Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. 276:39411-39418.
66. Schultz, C., Vaskinn, S., Kildalsen, H., Sager, G. (1998). Cyclic AMP stimulates the cyclic GMP egression pump in human erythrocytes: effects of probenecid, verapamil, progesterone, theophylline, IBMX, forskolin, and cyclic AMP on cyclic GMP uptake and association to inside-out vesicles. Biochemistry 37:1161-1166.
67. Spector, S. A., McKinley, G. F., Lalezari, J. P., Samo, T., Andruczk, R., Follansbee, S., Sparti, P. D., Havlir, D. V., Simpson, G., Buhles, W., Wong, R., Stempien, M. (1996). Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche cooperative oral ganciclovir study group. N. Engl. J. Med. 334:1491-1497.
68. Sundkvist, E., Jaeger, R., Sager, G. (2000). Leukotriene C(4) (LTC(4)) does not share a cellular efflux mechanism with cGMP: characterisation of cGMP transport by uptake to inside-out vesicles from human erythrocytes. Biochim. Biophys. Acta 1463:121-130.
69. Touraine, R. L., Ishii-Morita, H., Ramsey, W. J., Blaese, R. M. (1998). The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication. Gene Ther. 5:1705-1711.
70. van Aubel, R. A., Smeets, P. H., Peters, J. G., Bindels, R. J., Russel, F. G. (2002). The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol. 13:595-603.
71. Vogelgesang, S., Kunert-Keil, C., Cascorbi, I., Mosyagin, I., Schröder, E., Runge, U., Jedlitschky, G., Kroemer, H. K., Örtel, M., Gaab, M. R., Pahnke, J., Walker, L. C., Warzok, R. (2004). Expression of multidrug transporters in dysembryoblastic neuroepithelial tumors causing medically intractable epilepsy. Clin. Neuropathol. 23:223-231.
72. Vogt, M. H., Stet, E. H., De Abreu, R. A., Bokkerink, J. P., Lambooy, L. H., Trijbels, F. J. (1993). The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts. Biochim. Biophys. Acta 1181:189-194.
73. Wielinga, P. R., Reid, G., Challa, E. E., van der Heijden, I., van Deemter, L., de Haas, M., Mol, C., Kuil, A. J., Groeneveld, E., Schuetz, J. D., Brouwer, C., De Abreu, R. A., Wijnholds, J., Beijnen, J. H., Borst, P. (2002). Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol. Pharmacol. 62:1321-1331.
74. Wielinga, P. R., van der Heijden, I., Reid, G., Beijnen, J. H., Wijnholds, J., Borst, P. (2003). Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J. Biol. Chem. 278:17664-17671.
75. Wijnholds, J., Mol, C. A., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., Balzarini, J., Borst, P. (2000). Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. U. S. A. 97:7476-7481.
76. Wollert, K. C., Fiedler, B., Gambaryan, S., Smolenski, A., Heineke, J., Butt, E., Trautwein, C., Lohmann, S. M., Drexler, H. (2002). Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 39:87-92.
77. Woods, M., Houslay, M. D. (1991). Desensitization of atriopeptin stimulated accumulation and extrusion of cyclic GMP from a kidney epithelial cell line (MDCK). Biochem. Pharmacol. 41:385-394.
78. Yabuuchi, H., Takayanagi, S., Yoshinaga, K., Taniguchi, N., Aburatani, H., Ishikawa, T. (2002). ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem. Biophys. Res. Commun. 299:410-417.
79. Yamazaki, M., Straus, F. H., Messina, M., Robinson, B. G., Takeda, T., Hashizume, K., DeGroot, L. J. (2004). Adenovirus-mediated tumor-specific combined gene therapy using herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma. Cancer Gene Ther. 11:8-15.
80. Zelcer, N., Reid, G., Wielinga, P., Kuil, A., van der Heijden, I., Schuetz, J. D., Borst, P. (2003). Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem. J. 371:361-367.